Discontinuation report ALTACE HCT
Report ID | 214017 |
Drug Identification Number | 02283174 |
Brand name | ALTACE HCT |
Common or Proper name | ALTACE HCT |
Company Name | BAUSCH HEALTH, CANADA INC. |
Market Status | DORMANT |
Active Ingredient(s) | HYDROCHLOROTHIAZIDE RAMIPRIL |
Strength(s) | 25MG 5MG |
Dosage form(s) | TABLET |
Route of administration | ORAL ORAL |
Packaging size | n/a |
ATC code | C09BA |
ATC description | ACE INHIBITORS, COMBINATIONS |
Reason for discontinuation | Manufacturing issues |
Anticipated discontinuation date | 2023-01-31 |
Actual discontinuation date | 2024-01-08 |
Remaining supply date | |
Discontinuation status | Discontinued |
Discontinuation decision reversal | No |
Information on remaining supply | |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 2150 BOUL. ST-ELZEAR OUEST LAVAL, QUEBEC CANADA H7L 4A8 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v4 | 2024-01-09 | French | Compare |
v3 | 2024-01-09 | English | Compare |
v2 | 2023-12-21 | French | Compare |
v1 | 2023-12-21 | English | Compare |
Showing 1 to 4 of 4